City

Zhengzhou (1)

Condition

Advanced NSCLC With EGFR Mutation (1)

Overall Status

Unknown status (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Henan Cancer Hospital (1)

Collaborator

Intervention

gefitinib (1)

s-1 plus gefitinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

advanced nsclc with egfr mutation

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced NSCLC With EGFR Mutation Trial in Zhengzhou (S-1 plus Gefitinib, Gefitinib)

Unknown status

Advanced NSCLC With EGFR Mutation

S-1 plus Gefitinib
Gefitinib

Zhengzhou, Henan, China

Henan Cancer Hospital

Jul 8, 2020